[Diagnosis of immunopathophysiology in bone marrow failure: clinical significance of autoantibody detection].
Takamatsu
Hiroyuki
H
Nakao
Shinji
S
D000741:Anemia, Aplastic / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies / Q000097:blood* / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D019748:Carbon-Carbon Double Bond Isomerases / Q000276:immunology*; D064006:Dodecenoyl-CoA Isomerase; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D013058:Mass Spectrometry / Q000379:methods; D008840:Microfilament Proteins / Q000276:immunology*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D015415:Biomarkers; D008840:Microfilament Proteins; C071058:moesin; D000069283:Rituximab; D019748:Carbon-Carbon Double Bond Isomerases; D064006:Dodecenoyl-CoA Isomerase; C119738:ECI2 protein, human